H Cortés-Funes Selected Research

H Cortés-Funes Research Topics

Disease

12	Neoplasms (Cancer) 07/2013 - 05/2000
11	Breast Neoplasms (Breast Cancer) 06/2013 - 06/2000
5	Neutropenia 12/2006 - 05/2000
3	Fever (Fevers) 12/2006 - 05/2000
3	Febrile Neutropenia 12/2006 - 01/2001
3	Infections 11/2001 - 05/2000
2	Disease Progression 03/2011 - 06/2008
2	Bacteremia 04/2005 - 05/2000
2	Squamous Cell Carcinoma of Head and Neck 12/2004 - 10/2002
1	Hemorrhage 03/2011
1	Hypertension (High Blood Pressure) 03/2011
1	Proteinuria 03/2011
1	Venous Thromboembolism 03/2011
1	Stomach Neoplasms (Stomach Cancer) 03/2009
1	Ovarian Neoplasms (Ovarian Cancer) 06/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2008
1	Exanthema (Rash) 02/2003
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2002
1	Sepsis (Septicemia) 01/2001
1	Thrombocytopenia (Thrombopenia) 01/2001
1	Asthenia 09/2000
1	Transitional Cell Carcinoma 09/2000
1	Radiodermatitis 02/2000
1	Seminoma 01/2000
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2000

Drug/Important Bio-Agent (IBA)

6	Gemcitabine FDA Link 07/2010 - 02/2000
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2013 - 01/2001
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2002 - 01/2001
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2001 - 06/2000
3	Capecitabine (Xeloda)FDA Link 07/2010 - 12/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2005 - 05/2000
2	Fluorouracil (Carac)FDA LinkGeneric 06/2013 - 10/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2013 - 06/2000
2	AnthracyclinesIBA 03/2011 - 07/2010
2	Cisplatin (Platino)FDA LinkGeneric 03/2009 - 12/2004
2	Vinorelbine (Navelbine)FDA LinkGeneric 12/2006 - 05/2003
2	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2001 - 01/2001
2	Alkylating AgentsIBA 11/2001 - 01/2001
2	Indicators and Reagents (Reagents)IBA 09/2001 - 01/2000
2	Monoclonal AntibodiesIBA 09/2001 - 06/2000
1	kahalalide FIBA 07/2013
1	Vincristine (Oncovin)FDA LinkGeneric 06/2013
1	liposomal doxorubicin (Doxil)FDA Link 06/2013
1	Prednisone (Sone)FDA LinkGeneric 06/2013
1	Bevacizumab (Avastin)FDA Link 03/2011
1	human ERBB2 proteinIBA 03/2011
1	taxaneIBA 03/2011
1	Estrogens (Estrogen)FDA Link 06/2008
1	Biological FactorsIBA 06/2008
1	ParaffinIBA 06/2008
1	Progesterone FDA LinkGeneric 06/2008
1	Gefitinib (Iressa)FDA Link 01/2008
1	ErbB Receptors (EGF Receptor)IBA 01/2008
1	Ceftazidime (Fortum)FDA LinkGeneric 12/2006
1	Amikacin (A.M.K)FDA LinkGeneric 12/2006
1	Cefepime (Maxipime)FDA LinkGeneric 12/2006
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2004
1	Thymidine PhosphorylaseIBA 12/2004
1	ancestimIBA 02/2003
1	Filgrastim (Neupogen)FDA Link 02/2003
1	Proteins (Proteins, Gene)FDA Link 09/2001
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2001
1	Estrogen ReceptorsIBA 09/2001
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2001
1	gamma-Linolenic AcidIBA 02/2001
1	Oleic Acid (Oleate)IBA 02/2001
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2001
1	Pharmaceutical PreparationsIBA 07/2000
1	EnzymesIBA 06/2000
1	QuinolonesIBA 05/2000
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2000
1	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2000
1	Tumor Biomarkers (Tumor Markers)IBA 01/2000
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2000
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2000
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2000

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 03/2011 - 05/2000
3	Therapeutics 12/2004 - 06/2000
2	Catheters 04/2005 - 10/2002
2	TP protocol 10/2002 - 09/2000
2	Platelet Transfusion (Blood Platelet Transfusions) 11/2001 - 01/2001
1	Neoadjuvant Therapy 12/2004
1	Radiotherapy 12/2004
1	Induction Chemotherapy 10/2002
1	Transplantation 05/2002
1	Length of Stay 01/2001
1	Combination Drug Therapy (Combination Chemotherapy) 06/2000
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 05/2000